BRAIN Biotech AG (LON: 0RFI)

BRAIN Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	27.17	27.17	5.35	8.44	24.55	18.94
Short-Term Investments	0.06	0.06	0.06	0.08	0.06	0.05
Cash & Short-Term Investments	27.23	27.23	5.41	8.53	24.6	19
Cash Growth	403.59%	403.59%	-36.57%	-65.35%	29.50%	24.78%
Accounts Receivable	7.8	7.8	9.44	8.04	6.72	6.17
Other Receivables	0.32	0.32	0.27	3.24	0.13	0.17
Receivables	8.24	8.24	9.83	11.35	6.95	6.57
Inventory	9.42	9.42	9.76	9.66	7.02	6.96
Prepaid Expenses	0.6	0.6	0.39	0.33	0.32	0.28
Other Current Assets	0.17	0.17	0.09	0.52	0.23	0.28
Total Current Assets	45.66	45.66	25.48	30.38	39.11	33.08
Property, Plant & Equipment	27.86	27.86	28.72	28.74	24.29	24.47
Long-Term Investments	0.97	0.97	1.46	1.94	0.55	1
Goodwill	6.81	6.81	6.67	6.61	4.73	4.48
Other Intangible Assets	7.38	7.38	8.55	10.16	8.81	8.79
Long-Term Deferred Charges	0.07	0.07	0.02	0.06	-	0.11
Other Long-Term Assets	0	0	-	0.01	0.1	0.02
Total Assets	88.74	88.74	70.94	77.99	77.74	72.15
Accounts Payable	5.61	5.61	5.62	6.75	3.83	3.17
Accrued Expenses	5.91	5.91	3.6	2.67	2.28	3.45
Current Portion of Long-Term Debt	7.41	7.41	2.26	1.43	1.24	1.25
Current Portion of Leases	1.57	1.57	1.44	1.27	1.08	1.08
Current Income Taxes Payable	-	-	0.04	0.17	0.06	0.19
Current Unearned Revenue	0.62	0.62	2.93	1.99	1.57	0.86
Other Current Liabilities	3.89	3.89	1.59	7.1	1.27	2.35
Total Current Liabilities	25.01	25.01	17.48	21.39	11.34	12.36
Long-Term Debt	10.71	10.71	-	2.62	3.48	4.22
Long-Term Leases	6.62	6.62	6.74	5.41	5.58	6.53
Long-Term Unearned Revenue	1.12	1.12	0.52	0.77	1.11	1.37
Long-Term Deferred Tax Liabilities	3.88	3.88	3.77	3.29	2.79	2.16
Other Long-Term Liabilities	26.59	26.59	18.49	9.11	9.35	16.57
Total Liabilities	74.85	74.85	47.92	43.74	35.91	46.01
Common Stock	21.85	21.85	21.85	21.85	21.85	19.86
Additional Paid-In Capital	94.95	94.95	93.46	92.66	95.89	78.39
Retained Earnings	-105.49	-105.49	-94.16	-85.2	-79.51	-77.5
Comprehensive Income & Other	1.31	1.31	0.63	0.33	0.56	0.04
Total Common Equity	12.62	12.62	21.77	29.64	38.78	20.79
Minority Interest	1.27	1.27	1.24	4.61	3.04	5.36
Shareholders' Equity	13.89	13.89	23.01	34.25	41.83	26.14
Total Liabilities & Equity	88.74	88.74	70.94	77.99	77.74	72.15
Total Debt	26.3	26.3	10.44	10.74	11.38	13.09
Net Cash (Debt)	0.93	0.93	-5.03	-2.21	13.22	5.91
Net Cash Growth	-	-	-	-	123.82%	-25.05%
Net Cash Per Share	0.04	0.04	-0.23	-0.10	0.66	0.32
Filing Date Shares Outstanding	21.85	21.85	21.85	21.85	21.85	18.06
Total Common Shares Outstanding	21.85	21.85	21.85	21.85	21.85	18.06
Working Capital	20.65	20.65	8	9	27.78	20.73
Book Value Per Share	0.58	0.58	1.00	1.36	1.78	1.15
Tangible Book Value	-1.57	-1.57	6.56	12.87	25.25	7.51
Tangible Book Value Per Share	-0.07	-0.07	0.30	0.59	1.16	0.42
Land	10.66	10.66	10.42	10.33	16.26	16.03
Machinery	22.38	22.38	21.55	22.68	20.59	18.88

Source: S&P Capital IQ. Standard template. Financial Sources.